Bob Li: COSMOS Lung’s Efforts to Bridge Gaps in Lung Cancer Care
Bob Li: COSMOS Lung’s Efforts to Bridge Gaps in Lung Cancer Care Oncodaily
Bob Li: COSMOS Lung’s Efforts to Bridge Gaps in Lung Cancer Care Oncodaily
FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer Mega Doctor News
ECO Calls for Action to Strengthen Europe’s Role in Cancer Research and Improve Access to New Treatments Oncodaily
Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests | Newswise Newswise
American Cancer Society-led research to be presented at the 2026 ASCO Quality Care Symposium
The American Cancer Society led research to be presented at the 2026 ASCO Quality Care Symposium
Estela Rodriguez Highlights Mentorship and the Next Generation of Lung Cancer Researchers at DC Lung 2026 Oncodaily
UICC Invites Participants to Register for World Health Summit Event on Cancer Prevention and Health Promotion Oncodaily
Moffitt Researchers work to advance Dendritic Cell Therapy to treat breast cancer Tampa Bay 28
“Great Vision to Fulfill High Expectations” - Nagi El Saghir, Founding President of the Lebanese Society of Medical Oncology and Co-Founder of the Arab Medical Association Against Cancer, on Dr Gevorg Tamamyan’s Candidacy for WHO Director-General Oncodaily
“I Have Enormous Admiration for His Leadership, Vision, and, Above All, His Humanity. His Candidacy Fills Me With Pride, Confidence, and Hope” - Alejandra Mendez, President of Childhood Cancer International, Supports Gevorg Tamamyan’s Candidacy for Oncodaily
Metastatic Breast Cancer Patient Continues To Watch Family Grow Thanks to Clinical Trial Moffitt
Northwestern Medicine scientists have identified a stem-like state in small-cell lung cancer that distinguishes a group of patients with exceptionally poor outcomes following chemoimmunotherapy, according to a study published in Cell Reports Medicine.
Researchers in Adelaide and Singapore have uncovered new clues as to why some people with chronic myeloid leukemia (CML) respond better to treatment than others, finding that mitochondrial function in cancer cells could be targeted to improve responses.
Secure Your Place at the European Cancer Summit and Help Shape the Future of Cancer Research - ECO Oncodaily